Company: CL
Filing Date: 2025-03-26
Form Type: DEF 14A
Source: 0001308179-25-000223
Chunk: 35

Company: COLGATE PALMOLIVE CO
Filing Date: 2025-03-26
Form: DEF 14A
Chunk 35
---
 of the CD&A and the Grants of Plan-Based Awards Table.

| 2025            
 Proxy Statement | 45 |

Executive Compensation

| (3) | Option                                                                                           
 Awards. This column reflects the aggregate grant date fair value of annual stock                 
 option awards granted to each Named Officer in the years reported under the stockholder-approved 
 2019 Plan. The estimated value of stock options is calculated using the Black-Scholes            
 model. For a description of the assumptions used to calculate the amounts, see Note 7            
 (“Capital Stock and Stock-Based Compensation Plans”) to our Consolidated                         
 Financial Statements included in our Annual Report on Form 10-K for the year ended December      
 31, 2024. For more information regarding these awards, including their terms and conditions,     
 see page 40 of the CD&A and the Grants of Plan-Based Awards Table.                               |

| (4) | Non-Equity                                                                                    
 Incentive Plan Compensation. This column reflects the cash bonuses earned by the              
 Named Officers under the stockholder-approved 2019 Plan based on one or more pre-established  
 performance measures, as discussed more fully on pages 38 to 39 of the CD&A. These            
 bonuses were awarded and paid after audited financial results for the years for which         
 performance was measured were known early in the following year. See the Grants of Plan-Based 
 Awards Table for more information regarding 2024 bonuses.                                     |

| (5) | Change                                                                                        
 in Pension Value. This column reflects (i) for Ms. Parameswaran and Messrs. Tsourapas         
 and Wallace, the aggregate change in the actuarial present value of their accumulated         
 benefit under the Retirement Plan and the Colgate-Palmolive Company Supplemental Salaried     
 Employees’ Retirement Plan (the “Supplemental Retirement Plan”) from                          
 December 31, 2023 to December 31, 2024, December 31, 2022 to December 31, 2023 and December   
 31, 2021 to December 31, 2022, as applicable, reflecting additional interest credited         
 to their plan accounts as described on page 50 and (ii) for Mr. Wallace, above-market         
 interest earned during those periods ($1,211 in 2024) under the Colgate-Palmolive Company     
 Supplemental Savings and Investment Plan (the “Supplemental Savings & Investment              
 Plan”), as described on page 52. None of the Named Officers except Mr